MTOR and neoplasm: Given the low numbers of patients, 9 in each cohort, with adequate blood samples available for analysis in a time dependent manner, no definitive conclusion can be drawn on the utility of blood metformin concentration analysis to assess tumor related mTOR inhibition by metformin.